{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:58:20Z","timestamp":1767707900070},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T00:00:00Z","timestamp":1260489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12032-009-9375-9","type":"journal-article","created":{"date-parts":[[2009,12,10]],"date-time":"2009-12-10T19:20:56Z","timestamp":1260472856000},"page":"1286-1294","source":"Crossref","is-referenced-by-count":16,"title":["Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence"],"prefix":"10.1007","volume":"27","author":[{"given":"Sanaa","family":"Eissa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir F.","family":"Zohny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel-Rahman N.","family":"Zekri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek Mostafa","family":"El-Zayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany M.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,11]]},"reference":[{"key":"9375_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00345-007-0168-5","volume":"25","author":"C Murta-Nascimento","year":"2007","unstructured":"Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, Steineck G, Kogevinas M, Real FX, et al. Epidemiology of urinary bladder cancer: from tumor development to patient\u2019s death. World J Urol. 2007;25:285\u201395.","journal-title":"World J Urol"},{"key":"9375_CR2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cccn.2003.11.008","volume":"340","author":"P Dey","year":"2004","unstructured":"Dey P. Urinary markers of bladder carcinoma. Clin Chim Acta. 2004;340:57\u201365.","journal-title":"Clin Chim Acta"},{"key":"9375_CR3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.clinbiochem.2008.08.085","volume":"41","author":"S Eissa","year":"2008","unstructured":"Eissa S, Zohny SF, Swellam M, Mahmoud MH, El-Zayat TM, Salem AM. Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer. Clin Biochem. 2008;41:1335\u201341.","journal-title":"Clin Biochem"},{"key":"9375_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.matbio.2005.06.008","volume":"24","author":"Y Mao","year":"2005","unstructured":"Mao Y, Schwarzbauer JE. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 2005;24:389\u201399.","journal-title":"Matrix Biol"},{"key":"9375_CR5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000052456","volume":"39","author":"G Kirkali","year":"2001","unstructured":"Kirkali G, Tuzel E, Guler C, Gezer S, Kirkali Z. Significance of tissue laminin P(1) elastase and fibronectin levels in transitional cell carcinoma of the bladder. Eur Urol. 2001;39:292\u20139.","journal-title":"Eur Urol"},{"key":"9375_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00345-008-0357-x","volume":"27","author":"RF Youssef","year":"2009","unstructured":"Youssef RF, Mitra AP, Bartsch G, Jones PA, Skinner DG, Cote RJ. Molecular targets and targeted therapies in bladder cancer management. World J Urol. 2009;27:9\u201320.","journal-title":"World J Urol"},{"key":"9375_CR7","first-page":"171","volume":"8","author":"ML Lu","year":"2002","unstructured":"Lu ML, Wikman F, Orntoft TF, Charytonowicz E, Rabbani F, Zhang Z, et al. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods. Clin Cancer Res. 2002;8:171\u20139.","journal-title":"Clin Cancer Res"},{"key":"9375_CR8","first-page":"7530","volume":"63","author":"JC Schroeder","year":"2003","unstructured":"Schroeder JC, Conway K, Li Y, Mistry K, Bell DA, Taylor JA. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors. Cancer Res. 2003;63:7530\u20138.","journal-title":"Cancer Res"},{"key":"9375_CR9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1078-1439(03)00014-0","volume":"21","author":"HM Khaled","year":"2003","unstructured":"Khaled HM, Bahnassi AA, Zekri A-RN, Kassem AH, Mokhtar N. Correlation between p53 mutations and HPV in bilharzial bladder cancer. Urol Oncol. 2003;21:334\u201341.","journal-title":"Urol Oncol"},{"key":"9375_CR10","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/1097-0142(20010601)91:11<2127::AID-CNCR1241>3.0.CO;2-R","volume":"91","author":"JL Prescott","year":"2001","unstructured":"Prescott JL, Montie J, Pugh TW, McHugh T, Veltri RW. Clinical sensitivity of p53 mutation detection in matched bladder tumor, bladder wash, and voided urine specimens. Cancer. 2001;91:2127\u201335.","journal-title":"Cancer"},{"key":"9375_CR11","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/carcin\/bgh256","volume":"25","author":"B Schlichtholz","year":"2004","unstructured":"Schlichtholz B, Presler M, Matuszewski M. Clinical implications of p53 mutation analysis in bladder cancer tissue and urine sediment by functional assay in yeast. Carcinogenesis. 2004;25:2319\u201323.","journal-title":"Carcinogenesis"},{"key":"9375_CR12","first-page":"241","volume-title":"Cancer staging manual","author":"American Joint Committee on Cancer (AJCC)","year":"1997","unstructured":"American Joint Committee on Cancer (AJCC). Cancer staging manual. 5th ed. Lippincott-Raven: Philadelphia; 1997. p. 241.","edition":"5"},{"key":"9375_CR13","first-page":"187","volume-title":"UICC TNM classification of malignant tumors","author":"LH Sobin","year":"1997","unstructured":"Sobin LH, Wittkind CH. UICC TNM classification of malignant tumors. 5th ed. ed. New York: Wiley Liss; 1997. p. 187.","edition":"5"},{"key":"9375_CR14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0302-2838(03)00417-2","volume":"44","author":"S Eissa","year":"2003","unstructured":"Eissa S, Labib RA, Mourad MS, Kamel K, El-Ahmady O. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer. Eur Urol. 2003;44:687\u201394.","journal-title":"Eur Urol"},{"key":"9375_CR15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/00034983.1991.11812615","volume":"85","author":"M Gui","year":"1991","unstructured":"Gui M, Idris MA, Shi YE, Muhling A, Ruppel A. Reactivity of Schistosoma japonicum and S. mansoni antigen preparations in indirect haemagglutination (IHA) with sera of patients with homologous and heterologous schistosomiasis. Ann Trop Med Parasitol. 1991;85:599\u2013604.","journal-title":"Ann Trop Med Parasitol"},{"key":"9375_CR16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1126\/science.101.2629.519","volume":"101","author":"GN Papanicolaou","year":"1945","unstructured":"Papanicolaou GN, Marshall VF. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science. 1945;101:519\u201320.","journal-title":"Science"},{"key":"9375_CR17","first-page":"42","volume-title":"Molecular cloning. A laboratory manual","author":"J Sambrook","year":"1989","unstructured":"Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1989. p. 42\u201359.","edition":"2"},{"key":"9375_CR18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1054\/bjoc.1999.0890","volume":"82","author":"HA Phillips","year":"2000","unstructured":"Phillips HA, Howard GCW, Miller WR. p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer. Br J Cancer. 2000;82:136\u201341.","journal-title":"Br J Cancer"},{"key":"9375_CR19","first-page":"1444","volume":"9","author":"H Wang","year":"2003","unstructured":"Wang H, Chen XP, Qiu FZ. Overcoming multi-drug resistance by anti-MDR1 ribozyme. World J Gastroenterol. 2003;9:1444\u20139.","journal-title":"World J Gastroenterol"},{"key":"9375_CR20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/clinchem\/44.7.1397","volume":"44","author":"BS Bharaj","year":"1998","unstructured":"Bharaj BS, Angelopoulou K, Diamandis EP. Rapid sequencing of the p53 gene with a new automated DNA sequencer. Clin Chem. 1998;44:1397\u2013403.","journal-title":"Clin Chem"},{"key":"9375_CR21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29\u201336.","journal-title":"Radiology"},{"key":"9375_CR22","volume-title":"Analysis of survival data","author":"DR Cox","year":"1984","unstructured":"Cox DR, Oakes D. Analysis of survival data. London: Chapmann and Hall; 1984."},{"key":"9375_CR23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0022-5347(05)64659-9","volume":"168","author":"S Eissa","year":"2002","unstructured":"Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors. J Urol. 2002;168:465\u20139.","journal-title":"J Urol"},{"key":"9375_CR24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.urology.2004.09.028","volume":"65","author":"V Menendez","year":"2005","unstructured":"Menendez V, Fernandez-Suarez A, Galan JA, Perez M, Garcia-Lopez F. Diagnosis of bladder cancer by analysis of urinary fibronectin. Urology. 2005;65:284\u20139.","journal-title":"Urology"},{"key":"9375_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0009-8981(93)90158-Z","volume":"217","author":"M Katayama","year":"1993","unstructured":"Katayama M, Kamihagi K, Nakagawa K, Akiyama T, Sano Y, Ouchi R, et al. Increased fragmentation of urinary fibronectin in cancer patients detected by immunoenzymometric assay using domain-specific monoclonal antibodies. Clin Chim Acta. 1993;217:115\u201328.","journal-title":"Clin Chim Acta"},{"key":"9375_CR26","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/clinchem\/42.6.858","volume":"42","author":"VE Velculesu","year":"1996","unstructured":"Velculesu VE, El-Deiry WS. Biological and clinical importance of the p53 tumor suppressor gene. Clin Chem. 1996;42:858\u201368.","journal-title":"Clin Chem"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9375-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9375-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T05:53:59Z","timestamp":1590299639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9375-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,11]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9375"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9375-9","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,11]]}}}